/5
0 avis
Targeting triple-negative breast cancer and high-grade ovarian carcinoma: refining BRCAness beyond BRCA1/2 mutations?
Archive ouverte
Edité par CCSD ; Future Medicine -
International audience
Consulter en ligne
Chargement des enrichissements...